Tolerability Study of Xerecept® in Pediatric Patients

Summary

This study is being conducted to evaluate the safety and tolerability of Xerecept® in children with central nervous system tumors and to identify appropriate doses of Xerecept® to be used in subsequent pediatric clinical trials.

Timeline

Start

2010-06

Primary completion

2012-10

Completion

2013-03

Outcome

Outcome not reported

Stopped: “Single subject remained on study - transferred to compassionate use”

Drugs

Indications